Dysfunction of Inflammatory Pathways and Their Relationship with Anti-Hypothalamic Autoantibodies in Patients with Anorexia Nervosa.
IL-21
anorexia nervosa
duration of illness
pro-inflammatory cytokines
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
05 May 2023
05 May 2023
Historique:
received:
15
03
2023
revised:
27
04
2023
accepted:
03
05
2023
medline:
13
7
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
epublish
Résumé
Despite several attempts, the etiopathogenesis of anorexia nervosa (AN) is still unknown. However, the activation of the immune response in neuropsychiatric diseases, including AN, is increasingly evident. We aimed to explore immune response parameters in patients with AN and identify the link between the presence of specific autoantibodies for hypothalamic antigens and the inflammatory response. The relationship between inflammatory markers and the duration of the disease has been also investigated. Twenty-two patients with AN were included, and none were under psychopharmacological treatment or suffering from autoimmune conditions. Serum concentrations of interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, and IL-21 were determined by ELISA kits. In addition, autoantibodies against hypothalamic antigens are quantitatively evaluated. IL-6, IL-1 β, TNF-α, and TGF-β are significantly increased in patients with AN. A positive correlation with body mass index and with the amount of autoantibody specific for hypothalamic antigens exists. Notably, a progressive reduction of cytokines correlates with the progression of AN. In addition, IL-21 is increased in the blood of patients with AN and negatively correlates with autoantibody concentrations. This study shows that the increased pro-inflammatory phenotype in patients affected by AN correlates with the concentration of autoantibody specific for hypothalamic antigens. Of interest, the pro-inflammatory state seems to be reduced with duration of AN. In addition, IL-21 could work as a stimulant of the immune response, thus possibly increasing the autoreactivity.
Sections du résumé
BACKGROUND
BACKGROUND
Despite several attempts, the etiopathogenesis of anorexia nervosa (AN) is still unknown. However, the activation of the immune response in neuropsychiatric diseases, including AN, is increasingly evident. We aimed to explore immune response parameters in patients with AN and identify the link between the presence of specific autoantibodies for hypothalamic antigens and the inflammatory response. The relationship between inflammatory markers and the duration of the disease has been also investigated.
METHODS
METHODS
Twenty-two patients with AN were included, and none were under psychopharmacological treatment or suffering from autoimmune conditions. Serum concentrations of interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, and IL-21 were determined by ELISA kits. In addition, autoantibodies against hypothalamic antigens are quantitatively evaluated.
RESULTS
RESULTS
IL-6, IL-1 β, TNF-α, and TGF-β are significantly increased in patients with AN. A positive correlation with body mass index and with the amount of autoantibody specific for hypothalamic antigens exists. Notably, a progressive reduction of cytokines correlates with the progression of AN. In addition, IL-21 is increased in the blood of patients with AN and negatively correlates with autoantibody concentrations.
CONCLUSIONS
CONCLUSIONS
This study shows that the increased pro-inflammatory phenotype in patients affected by AN correlates with the concentration of autoantibody specific for hypothalamic antigens. Of interest, the pro-inflammatory state seems to be reduced with duration of AN. In addition, IL-21 could work as a stimulant of the immune response, thus possibly increasing the autoreactivity.
Identifiants
pubmed: 37432371
pii: nu15092199
doi: 10.3390/nu15092199
pmc: PMC10180712
pii:
doi:
Substances chimiques
Autoantibodies
0
Interleukin-6
0
Cytokines
0
Transforming Growth Factor beta
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
CNS Neurosci Ther. 2022 Dec;28(12):1921-1929
pubmed: 36114699
Pediatrics. 2017 Dec;140(6):
pubmed: 29122972
Curr Opin Psychiatry. 2022 Nov 1;35(6):362-371
pubmed: 36125216
Eur Eat Disord Rev. 2023 Jan;31(1):76-86
pubmed: 35751889
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109727
pubmed: 31398429
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Nutrition. 2001 Jul-Aug;17(7-8):664-8
pubmed: 11448593
J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):92-5
pubmed: 26757948
Nutrients. 2018 Oct 24;10(11):
pubmed: 30355978
Clin Exp Immunol. 1975 Aug;21(2):244-9
pubmed: 1102164
J Psychosom Res. 2017 Nov;102:47-53
pubmed: 28992897
Neuropsychopharmacology. 2012 Jan;37(1):137-62
pubmed: 21918508
mBio. 2020 Jul 21;11(4):
pubmed: 32694139
J Psychiatr Res. 2018 Aug;103:252-264
pubmed: 29906710
Brain Behav Immun Health. 2020 Oct 01;9:100154
pubmed: 34589896
Diabetes. 2009 May;58(5):1144-55
pubmed: 19208913
J Clin Med. 2021 Jun 09;10(12):
pubmed: 34207744
J Immunol. 2008 Apr 15;180(8):5393-401
pubmed: 18390721
Br J Pharmacol. 2018 Dec;175(24):4430-4438
pubmed: 29243233
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:92-100
pubmed: 22510462
Autoimmunity. 2020 Jun;53(4):225-230
pubmed: 32157915
Front Cell Neurosci. 2015 Oct 14;9:392
pubmed: 26528128
Eat Weight Disord. 2020 Apr;25(2):365-371
pubmed: 30368766
Adv Exp Med Biol. 1999;461:117-27
pubmed: 10442171
Ann Endocrinol (Paris). 2005 Feb;66(1):7-11
pubmed: 15798582
Cureus. 2022 Jun 24;14(6):e26296
pubmed: 35911274
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Am J Hematol. 2020 Apr;95(4):E98-E101
pubmed: 31944357
Eur J Immunol. 2023 Apr;53(4):e2250075
pubmed: 36811452
Biofactors. 2013 Jul-Aug;39(4):368-73
pubmed: 23553807
Nutrients. 2020 Oct 28;12(11):
pubmed: 33126427
Psychosom Med. 2015 Nov-Dec;77(9):969-81
pubmed: 26428446
Psychoneuroendocrinology. 2001 May;26(4):393-409
pubmed: 11259859
Q J Med. 1993 Dec;86(12):791-9
pubmed: 8108536
Eat Weight Disord. 2022 Oct;27(7):2481-2496
pubmed: 35297008
Int J Environ Res Public Health. 2022 Sep 11;19(18):
pubmed: 36141722
Cent Eur J Immunol. 2021;46(1):127-132
pubmed: 33897295
J Psychiatr Pract. 2010 Mar;16(2):82-92
pubmed: 20511732
Front Endocrinol (Lausanne). 2021 Apr 19;12:613983
pubmed: 33953692
PLoS One. 2014 Sep 25;9(9):e106463
pubmed: 25254642